Real-World Treatment Patterns, Resource Utilization, and Cost of Care in Medicare Beneficiaries Newly Diagnosed with Acute Myeloid Leukemia and Treated with Venetoclax-Based Regimens

被引：0
|
作者：
Roth, Joshua A. [1 ]
D'Amico, Paul G. [1 ]
Russell-Smith, Alexander [2 ]
Purcell, Simon [3 ]
Donckels, Elizabeth [4 ]
Cappelleri, Joseph C. [5 ]
Ma, Jia [1 ]
Petrilla, Allison [4 ]
Kagan, Jerry [4 ]
Yu, Anthony [4 ]
机构：
[1] Pfizer, New York, NY USA
[2] Pfizer R&D UK Ltd, Sandwich, England
[3] Pfizer, Sandwich, England
[4] Inovalon, Bowie, MD USA
[5] Pfizer Inc, Groton, CT USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-198239
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5191 / 5192
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD TREATMENT PATTERNS AND COSTS IN MEDICARE BENEFICIARIES NEWLY DIAGNOSED WITH ACUTE MYELOID LEUKEMIA
    Stein, E. M.
    Latremouille-Viau, D.
    Guerin, A.
    Shi, S.
    Gagnon-Sanschagrin, P.
    Briggs, O.
    Bonifacio, G.
    Joseph, G.
    VALUE IN HEALTH, 2017, 20 (05) : A104 - A104
  • [2] Real-World Experience with Venetoclax-Based Regimens for the Treatment of Acute Myeloid Leukemia
    Ceparano, Giusy
    Sciume, Mariarita
    Fabris, Sonia
    Barozzi, Enrico
    Rampi, Nicolo
    De Roberto, Pasquale
    Baldini, Luca
    Fracchiolla, Nicola Stefano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S298 - S298
  • [3] Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative
    Vachhani, Pankit
    Wolach, Ofir
    Garcia, Jacqueline S.
    Zeidner, Joshua F.
    Talati, Chetasi
    Pollyea, Daniel A.
    Lai, Catherine
    Moshe, Yakir
    Abedin, Sameem
    Lavie, David
    Zuckerman, Tsila
    Xavier, Marin
    Lee, Sangmin
    Chen, Evan
    Edwards, Wesleigh
    Bui, Cat N.
    Svensson, Anders
    Kye, Steve
    Burne, Rebecca
    Maitland, Jessica
    Ma, Esprit
    Montez, Melissa
    Grunspan, Moshe
    Goldberg, Aaron D.
    BLOOD, 2021, 138
  • [4] Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia
    Othman, Tamer A.
    Azenkot, Tali
    Moskoff, Benjamin N.
    Tenold, Matthew E.
    Jonas, Brian A.
    FUTURE ONCOLOGY, 2021, 17 (23) : 2989 - 3005
  • [5] Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
    Baden, David
    Zukunft, Sven
    Hernandez, Gema
    Wolgast, Nadine
    Steinhaeuser, Sophie
    Pohlmann, Alexander
    Schliemann, Christoph
    Mikesch, Jan-Henrik
    Steffen, Bjoern
    Sauer, Tim
    Hanoun, Maher
    Schaefer-Eckart, Kerstin
    Krause, Stefan W.
    Haenel, Mathias
    Einsele, Hermann
    Jost, Edgar
    Bruemmendorf, Tim H.
    Scholl, Sebastian
    Hochhaus, Andreas
    Neubauer, Andreas
    Burchert, Andreas
    Kaufmann, Martin
    Niemann, Dirk
    Schaich, Markus
    Blau, Wolfgang
    Kiani, Alexander
    Goerner, Martin
    Kaiser, Ulrich
    Kullmer, Johannes
    Weber, Thomas
    Berdel, Wolfgang E.
    Ehninger, Gerhard
    Mueller-Tidow, Carsten
    Platzbecker, Uwe
    Serve, Hubert
    Bornhaeuser, Martin
    Roellig, Christoph
    Baldus, Claudia D.
    Fransecky, Lars
    HAEMATOLOGICA, 2024, 109 (08) : 2469 - 2477
  • [6] Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Stein, Eytan M.
    Latremouille-Viau, Dominick
    Guerin, Annie
    Shi, Sherry
    Gagnon-Sanschagrin, Patrick
    Bonifacio, Gaetano
    Joseph, George J.
    BLOOD, 2016, 128 (22)
  • [7] Treatment of Acute Myeloid Leukemia With Venetoclax-Based Combinations in Argentina: A Real-World Study
    Rivero Equiza, Tomas
    Cazap, Nicolas
    Garcia Altuve, Juan Ignacio
    Fornillo, Florencia
    Maymo, Daniela
    Riera, Leandro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S323 - S324
  • [8] Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study
    Miyashita, Naoki
    Onozawa, Masahiro
    Matsukawa, Toshihiro
    Mori, Akio
    Hidaka, Daisuke
    Minauchi, Koichiro
    Shigematsu, Akio
    Hashiguchi, Junichi
    Igarashi, Tetsuyuki
    Kakinoki, Yasutaka
    Tsutsumi, Yutaka
    Ibata, Makoto
    Wakasa, Kentaro
    Fujimoto, Katsuya
    Ishihara, Toshimichi
    Sakai, Hajime
    Iyama, Satoshi
    Oyake, Tatsuo
    Kondo, Takeshi
    Teshima, Takanori
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1549 - 1553
  • [9] REAL-WORLD EFFECTIVENESS AND TREATMENT PATTERNS OF VENETOCLAX-BASED REGIMENS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN COMMUNITY SETTINGS
    Zakeri, M.
    Emechebe, N.
    Chowdhery, R.
    Jawaid, D.
    Alhasani, H.
    Manzoor, B. S.
    VALUE IN HEALTH, 2023, 26 (06) : S54 - S55
  • [10] Treatment Response and Impact Factor of Venetoclax Based Regimens in the Frontline Treatment of Newly Diagnosed Unfit Acute Myeloid Leukemia in the Real World of China
    Yu, Guopan
    Yin, Zhao
    Xu, Dan
    Jiang, Xuejie
    Ye, Jieyu
    Zhang, Yu
    BLOOD, 2022, 140 : 11740 - 11740
12345